Pete Storofilos
Analyst
Cantor
Equibles does not estimate personal net worth.
About Pete Storofilos
Pete Storofilos is recorded as Analyst at Cantor. Pete Storofilos has spoken on 2 investor events across 1 company, most recently for Acumen Pharmaceuticals, Inc. on September 16, 2026. The companies whose calls Pete Storofilos spoke on are classified in the Healthcare sector.
Pete Storofilos on recent calls
“You know, when you look at the baseline characteristics of those enrolled in altitude, how do they sort of compare to the enrolled in the registrational studies for lacanumab and denanumab?”
“You know, when you look at the baseline characteristics of those enrolled in altitude, how do they sort of compare to the enrolled in the registrational studies for lacanumab and denanumab?”
Affiliation history
-
Cantor
Analyst
Transcript header (unverified)
Current